Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Alcaraz A, Rodríguez-Antolín A, Carballido-Rodríguez J, Castro-Díaz D, Medina-Polo J, Fernández-Gómez JM, Ficarra V, Palou J, Ponce de León Roca J, Angulo JC, Esteban-Fuertes M, Cózar-Olmo JM, Pérez-León N, Molero-García JM, Fernández-Pro Ledesma A, Brenes-Bermúdez FJ, Manasanch J. Alcaraz A, et al. Sci Rep. 2021 Sep 29;11(1):19401. doi: 10.1038/s41598-021-98586-5. Sci Rep. 2021. PMID: 34588509 Free PMC article.
Assessment of the psychometric properties of the Spanish language version of questionnaire ICIQ-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS).
Castro-Díaz DM, Esteban-Fuertes M, Salinas-Casado J, Bustamante-Alarma S, Gago-Ramos JL, Galacho-Bech A, García-Matres MJ, Rodríguez-Toves LA, Zubiaur-Líbano C, Collado-Serra A, Batista-Miranda JE, Ortiz-Gámiz A; Grupo Ifu. Castro-Díaz DM, et al. Actas Urol Esp. 2014 Mar;38(2):71-7. doi: 10.1016/j.acuro.2013.07.005. Epub 2013 Oct 10. Actas Urol Esp. 2014. PMID: 24120839 English, Spanish.
The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women.
Jimenez-Cidre MA, Lopez-Fando L, Esteban-Fuertes M, Prieto-Chaparro L, Llorens-Martinez FJ, Salinas-Casado J, Castro-Diaz D, Müller-Arteaga C, Adot-Zurbano JM, Rodriguez-Escobar F, Gutierrez C, Arlandis-Guzman S, Bonillo-Garcia MA, Madurga-Patuel B, Leva-Vallejo M, Franco de Castro A, Peri-Cusi L, Conejero-Sugrañes J, Jimenez-Calvo J, Rebollo P, Mora A. Jimenez-Cidre MA, et al. Neurourol Urodyn. 2015 Feb;34(2):128-32. doi: 10.1002/nau.22530. Epub 2013 Nov 22. Neurourol Urodyn. 2015. PMID: 24264859
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies.
Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, Castro Díaz D, Romero-Otero J, Brenes FJ, Carballido J, Molero García JM, Fernández-Pro Ledesma A, Cózar Olmos JM, Manasanch Dalmau J, Subirana Cachinero I, Herdman M, Ficarra V. Vela-Navarrete R, et al. BJU Int. 2018 Dec;122(6):1049-1065. doi: 10.1111/bju.14362. Epub 2018 Jun 6. BJU Int. 2018. PMID: 29694707 Free article.
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Alcaraz A, Rodríguez-Antolín A, Carballido-Rodríguez J, Castro-Díaz D, Esteban-Fuertes M, Cózar-Olmo JM, Ficarra V, Medina-López R, Fernández-Gómez JM, Angulo JC, Medina-Polo J, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Manasanch J, The Qualiprost Study Group OBO. Alcaraz A, et al. J Clin Med. 2020 Sep 9;9(9):2909. doi: 10.3390/jcm9092909. J Clin Med. 2020. PMID: 32917008 Free PMC article.
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.
Alcaraz A, Gacci M, Ficarra V, Medina-Polo J, Salonia A, Fernández-Gómez JM, Ciudin A, Castro-Díaz D, Rodríguez-Antolín A, Carballido-Rodríguez J, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Ledesma AF, Herdman M, Manasanch J, Angulo JC, Group OBOTQS. Alcaraz A, et al. J Clin Med. 2022 Feb 12;11(4):967. doi: 10.3390/jcm11040967. J Clin Med. 2022. PMID: 35207238 Free PMC article.
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.
Alcaraz A, Castro-Díaz D, Gacci M, Salonia A, Ficarra V, Carballido-Rodríguez J, Rodríguez-Antolín A, Medina-Polo J, Fernández-Gómez JM, Cózar-Olmo JM, Búcar-Terrades S, Pérez-León N, Brenes-Bermúdez FJ, Molero-García JM, Fernández-Pro-Ledesma A, Herdman M, Angulo JC, Manasanch J, On Behalf Of The Qualiprost Study Group. Alcaraz A, et al. J Clin Med. 2022 Jun 22;11(13):3615. doi: 10.3390/jcm11133615. J Clin Med. 2022. PMID: 35806900 Free PMC article.
Bladder Capacity in Women With Overactive Bladder Syndrome: A Cross-sectional Study.
López-Fando Lavalle L, Calleja Hermosa P, Velasco Balanza C, Jiménez Cidre M, Gutiérrez Baños JL, Viegas V, Sánchez Ramírez A, Esteban Fuertes M, Gutiérrez Ruiz C, Peri Cusí L, Castro Díaz D, Arlandis Guzmán S. López-Fando Lavalle L, et al. Among authors: castro diaz d. Urology. 2023 Sep;179:44-49. doi: 10.1016/j.urology.2023.06.012. Epub 2023 Jun 21. Urology. 2023. PMID: 37353085
Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence.
Castro-Diaz D, Palma PC, Bouchard C, Haab F, Hampel C, Carone R, Zepeda Contreras S, Rodriguez Ginorio H, Voss S, Yalcin I, Bump RC; Duloxetine Dose Escalation Study Group. Castro-Diaz D, et al. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Aug;18(8):919-29. doi: 10.1007/s00192-006-0256-x. Epub 2006 Dec 12. Int Urogynecol J Pelvic Floor Dysfunct. 2007. PMID: 17160693 Clinical Trial.
109 results